| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
17,128.0670 | 17,128.0670 | 17,186.6770 | 13,971.7430 | 13,471.4710 |
|
Cost of Revenue
|
-13,885.0500 | -13,885.0500 | -13,829.4710 | -10,604.6400 | -10,659.1090 |
|
Gross Profit
|
3,243.0170 | 3,243.0170 | 3,357.2060 | 3,367.1030 | 2,812.3620 |
| Selling, General and Administrative Expenses
|
-2,885.6960 | -2,885.6960 | -2,951.6850 | -1,885.0560 | -1,823.0320 |
| Depreciation, Amortization and Depletion
|
-35.1010 | -35.1010 | -30.6040 | -32.8430 | -- |
|
Operating Income/Expenses
|
-2,920.7970 | -2,920.7970 | -2,982.2890 | -1,885.0560 | -1,823.0320 |
|
Total Operating Profit/Loss
|
322.2200 | 322.2200 | 374.9170 | 1,482.0470 | 989.3300 |
| Total Net Finance Income/Expense
|
99.7730 | 99.7730 | -211.3080 | -238.3550 | -173.5590 |
| Net Investment Income
|
-6.8660 | -6.8660 | -9.2730 | 19.1590 | 3.8620 |
|
Other Income/Expense, Non-Operating
|
15.2780 | 15.2780 | 74.6180 | 34.7820 | 35.6750 |
|
Non-Operating Income/Expenses, Total
|
108.1850 | 108.1850 | -145.9630 | -184.4140 | -134.0220 |
|
Pretax Income
|
430.4050 | 430.4050 | 228.9540 | 1,297.6330 | 855.3080 |
|
Provision for Income Tax
|
-194.7800 | -194.7800 | -19.2810 | -178.1010 | -110.8090 |
|
Net Income from Continuing Operations
|
235.6250 | 235.6250 | 209.6730 | 1,119.5320 | 744.4990 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
235.6250 | 235.6250 | 209.6730 | 1,119.5320 | 744.4990 |
|
Net Income after Non-Controlling/Minority Interests
|
235.6250 | 235.6250 | 209.6730 | 1,119.5320 | 744.4990 |
|
Net Income Available to Common Stockholders
|
235.6250 | 235.6250 | 209.6730 | 1,119.5320 | 744.4990 |
|
Diluted Net Income Available to Common Stockholders
|
235.6250 | 235.6250 | 209.6730 | 1,119.5320 | 744.4990 |
| Basic EPS
|
0.40 | 0.40 | 0.47 | 2.49 | 1.65 |
| Diluted EPS
|
0.40 | 0.40 | 0.47 | 2.49 | 1.65 |
|
Basic Weighted Average Shares Outstanding
|
443.3840 | 443.3840 | 450 | 450 | 450 |
|
Diluted Weighted Average Shares Outstanding
|
443.3840 | 443.3840 | 450 | 450 | 450 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
330.6320 | 330.6320 | 440.2620 | 1,535.9880 | 1,028.8670 |
|
EBITDA
|
599.2020 | 599.2020 | 703.1290 | 1,803.5890 | 1,339.0330 |
|
Normalized EBITDA
|
559.1910 | 559.1910 | 747.1280 | 1,869.3590 | 1,386.2720 |
|
Normalized Income
|
195.6140 | 195.6140 | 249.9761 | 1,176.2750 | 785.6180 |
|
Total Unusual Items
|
-40.0110 | -40.0110 | 43.9990 | 65.7700 | 47.2390 |
|
Total Unusual Items Excluding Goodwill
|
-40.0110 | -40.0110 | 43.9990 | 65.7700 | 47.2390 |
|
Tax Effect of Unusual Items
|
0 | 0 | 3.6959 | 9.0270 | 6.1200 |
3/31/2023 - 6/25/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade